+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lycopene Market by Form, Nature, and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5457282
  • Report
  • August 2021
  • Region: Global
  • 255 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • AromataGroup SRL
  • Chr Hasen A/S
  • DDW The Color
  • Doehler Group SE
  • Givaudan International SA
  • Kemin Industries, Inc.
Lycopene is a naturally occurring carotenoid. It is most commonly found in tomatoes, however, it is also found in other fruits and vegetables such as guavas, watermelon, grapefruit, red bell peppers, red carrots, papaya, and others. It is a color pigment that gives these fruits and vegetables their red color. Lycopene extracted from these sources is majorly used as a coloring agent or dye to impart red color to various kinds of foods, confectionaries, and beverages. Lycopene has high antioxidant concentration, which helps fight free radicals in the body and can also help prevent heart diseases and certain types of cancers. Due to this, the use of lycopene as an active ingredient in nutraceuticals and some pharmaceuticals has increased significantly. Furthermore, antioxidants also help in skin tightening and overall skin improvement, as a result its adoption has witnessed surge in the cosmetic and personal care products.

Increase in demand for natural food colors from various industries such as food & beverages, bakery & confectionery, dairy products, meat & poultry, and seafood, to have a positive impact on the growth of the lycopene market as a coloring agent. Lycopene imparts red color to food and beverages, which make the food aesthetically pleasing and attractive to consumers. Furthermore, natural lycopene is obtained from tomatoes; thus, also have nutritious benefits along with less susceptibility to any allergic reactions. In addition, increase in consumer awareness toward usage of natural ingredients in food production has increased in the last few years. As a result, consumers are opting for alternatives for food and beverages free from synthetic colors. With increasing preference for natural colors, demand for natural lycopene is expected to gain high traction in the near future.

The most common application of lycopene is as a coloring agent to impart red color to food, beverages, cakes, confectionaries, meat, and others. However, lycopene is not the only natural source from which red food color dyes are made. Beetroot is a major vegetable from which red food dye is manufactured. Red carrots, astaxanthin, apocarotenal, and others are some other commonly used sources for production of red food dye. The presence of a large variety of natural sources of food color production undermines the importance of lycopene. Food manufacturers have multiple different options they can choose from, depending on the availability and cost effectiveness of the color. This severely impacts the lycopene market and can become a barrier that can dissuade market expansion.

The global lycopene market is segmented on the basis of form, nature, application, and region. Based on form, the global lycopene market is bifurcated into powder and others. By nature, the market is bifurcated into natural and synthetic. Based on application the global market is segmented into food and beverage, nutraceuticals and pharmaceuticals, and cosmetics and personal care. The global lycopene market is also studied across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players profiled for in the lycopene market analysis include Allied Biotech Corporation, Archer-Daniels-Midland Company, AromataGroup SRL, BASF SE, Divis Laboratories Ltd., Doehler Group SE, ExcelVite, Givaudan International SA, Kalsec Inc., and Koninklijke DSM N.V. Other prominent players analyzed in the report are Chr Hasen A/S, DDW The Color House, International Flavors & Fragrances Inc., Sensient Technologies Corporation, Cyanotech Corporation, and Kemin Industries, Inc.

Lycopene Market Segments


By Form:

  • Powder
  • Others

By Nature:

  • Natural
  • Synthetic

By Application:

  • Food and Beverage
  • Nutraceuticals and pharmaceuticals
  • Cosmetics and Personal Care

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Argentina
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Allied Biotech Corporation
  • Archer-Daniels-Midland Company
  • AromataGroup SRL
  • BASF SE
  • Divis Laboratories Ltd.
  • Doehler Group SE
  • ExcelVite
  • Givaudan International SA
  • Kalsec Inc.
  • Koninklijke DSM N.V
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AromataGroup SRL
  • Chr Hasen A/S
  • DDW The Color
  • Doehler Group SE
  • Givaudan International SA
  • Kemin Industries, Inc.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective
2.3. View of Engaged Stakeholders

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Porter's five forces analysis
3.2.1. Bargaining power of suppliers
3.2.2. Bargaining power of buyers
3.2.3. Threat of substitution
3.2.4. Threat of new entrants
3.2.5. Intensity of competitive rivalry
3.3. Parent market overview
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Use of lycopene as a natural coloring agent in food and beverages to drive the market growth
3.4.1.2. Various health benefits of lycopene to benefit the nutraceutical industry
3.4.1.3. Skin repairing and skin improving qualities of lycopene to increase its adoption in cosmetic industry
3.4.2. Restraints
3.4.2.1. Availability of several other sources for red food coloring to impede market growth
3.4.2.2. Low stability of lycopene to challenge market expansion
3.4.3. Opportunities
3.4.3.1. Increase in consumer demand for clean label products can help provide impetus to the market
3.4.3.2. Newer demand from the animal feed industry can help create new growth avenues
3.5. Industry life cycle assessment, by region
3.6. Geographical concentration analysis of lycopene producers

CHAPTER 4: GLOBAL LYCOPENE MARKET, BY FORM

4.1. Overview
4.1.1. Market size and forecast, by Form
4.2. Powder
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Others
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: GLOBAL LYCOPENE MARKET, BY NATURE

5.1. Overview
5.1.1. Market size and forecast, by Nature
5.2. Natural
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Synthetic
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country

CHAPTER 6: GLOBAL LYCOPENE MARKET, BY APPLICATION

6.1. Overview
6.1.1. Market size and forecast, by Application
6.2. Food and Beverage
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Nutraceuticals and Pharmaceuticals
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Cosmetics and Personal Care
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country

CHAPTER 7: LYCOPENE MARKET, BY REGION

7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Overview
7.2.2. Key market trends, growth factors, and opportunities
7.2.3. Market size and forecast, by Form
7.2.4. Market size and forecast, by Nature
7.2.5. Market size and forecast, by Application
7.2.6. Market analysis, by Country
7.2.6.1. U.S.
7.2.6.1.1. Market size and forecast, by Form
7.2.6.1.2. Market size and forecast, by Nature
7.2.6.1.3. Market size and forecast, by Application
7.2.6.2. Canada
7.2.6.2.1. Market size and forecast, by Form
7.2.6.2.2. Market size and forecast, by Nature
7.2.6.2.3. Market size and forecast, by Application
7.2.6.3. Mexico
7.2.6.3.1. Market size and forecast, by Form
7.2.6.3.2. Market size and forecast, by Nature
7.2.6.3.3. Market size and forecast, by Application
7.3. Europe
7.3.1. Overview
7.3.2. Key market trends, growth factors, and opportunities
7.3.3. Market size and forecast, by Form
7.3.4. Market size and forecast, by Nature
7.3.5. Market size and forecast, by Application
7.3.6. Market analysis, by Country
7.3.6.1. UK
7.3.6.1.1. Market size and forecast, by Form
7.3.6.1.2. Market size and forecast, by Nature
7.3.6.1.3. Market size and forecast, by Application
7.3.6.2. Germany
7.3.6.2.1. Market size and forecast, by Form
7.3.6.2.2. Market size and forecast, by Nature
7.3.6.2.3. Market size and forecast, by Application
7.3.6.3. France
7.3.6.3.1. Market size and forecast, by Form
7.3.6.3.2. Market size and forecast, by Nature
7.3.6.3.3. Market size and forecast, by Application
7.3.6.4. Italy
7.3.6.4.1. Market size and forecast, by Form
7.3.6.4.2. Market size and forecast, by Nature
7.3.6.4.3. Market size and forecast, by Application
7.3.6.5. Spain
7.3.6.5.1. Market size and forecast, by Form
7.3.6.5.2. Market size and forecast, by Nature
7.3.6.5.3. Market size and forecast, by Application
7.3.6.6. Rest of Europe
7.3.6.6.1. Market size and forecast, by Form
7.3.6.6.2. Market size and forecast, by Nature
7.3.6.6.3. Market size and forecast, by Application
7.4. Asia-Pacific
7.4.1. Overview
7.4.2. Key market trends, growth factors, and opportunities
7.4.3. Market size and forecast, by Form
7.4.4. Market size and forecast, by Nature
7.4.5. Market size and forecast, by Application
7.4.6. Market analysis, by country
7.4.6.1. China
7.4.6.1.1. Market size and forecast, by Form
7.4.6.1.2. Market size and forecast, by Nature
7.4.6.1.3. Market size and forecast, by Application
7.4.6.2. Japan
7.4.6.2.1. Market size and forecast, by Form
7.4.6.2.2. Market size and forecast, by Nature
7.4.6.2.3. Market size and forecast, by Application
7.4.6.3. India
7.4.6.3.1. Market size and forecast, by Form
7.4.6.3.2. Market size and forecast, by Nature
7.4.6.3.3. Market size and forecast, by Application
7.4.6.4. ASEAN
7.4.6.4.1. Market size and forecast, by Form
7.4.6.4.2. Market size and forecast, by Nature
7.4.6.4.3. Market size and forecast, by Application
7.4.6.5. Australia
7.4.6.5.1. Market size and forecast, by Form
7.4.6.5.2. Market size and forecast, by Nature
7.4.6.5.3. Market size and forecast, by Application
7.4.6.6. South Korea
7.4.6.6.1. Market size and forecast, by Form
7.4.6.6.2. Market size and forecast, by Nature
7.4.6.6.3. Market size and forecast, by Application
7.4.6.7. Rest of Asia-Pacific
7.4.6.7.1. Market size and forecast, by Form
7.4.6.7.2. Market size and forecast, by Nature
7.4.6.7.3. Market size and forecast, by Application
7.5. LAMEA
7.5.1. Overview
7.5.2. Key market trends, growth factors, and opportunities
7.5.3. Market size and forecast, by Form
7.5.4. Market size and forecast, by Nature
7.5.5. Market size and forecast, by Application
7.5.6. Market analysis, by country
7.5.6.1. Brazil
7.5.6.1.1. Market size and forecast, by Form
7.5.6.1.2. Market size and forecast, by Nature
7.5.6.1.3. Market size and forecast, by Application
7.5.6.2. Argentina
7.5.6.2.1. Market size and forecast, by Form
7.5.6.2.2. Market size and forecast, by Nature
7.5.6.2.3. Market size and forecast, by Application
7.5.6.3. Saudi Arabia
7.5.6.3.1. Market size and forecast, by Form
7.5.6.3.2. Market size and forecast, by Nature
7.5.6.3.3. Market size and forecast, by Application
7.5.6.4. South Africa
7.5.6.4.1. Market size and forecast, by Form
7.5.6.4.2. Market size and forecast, by Nature
7.5.6.4.3. Market size and forecast, by Application
7.5.6.5. Rest of LAMEA
7.5.6.5.1. Market size and forecast, by Form
7.5.6.5.2. Market size and forecast, by Nature
7.5.6.5.3. Market size and forecast, by Application

CHAPTER 8: COMPETITION LANDSCAPE

8.1. Overview
8.2. Competitive dashboard
8.3. Competitive heat map
8.4. Product mapping
8.5. Top winning strategies
8.6. Key developments
8.6.1. Acquisition
8.6.2. Business Expansion
8.6.3. Product Launch
8.6.4. Partnership
8.6.5. Agreement
8.6.6. Collaboration
8.6.7. Joint venture
8.6.8. Merger
8.7. Top Player Positioning

CHAPTER 9: COMPANY PROFILE

9.1. ALLIED BIOTECH CORPORATION
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. ARCHER DANIELS MIDLAND COMPANY
9.2.1. Company overview
9.2.2. Key executive
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. R&D expenditure
9.2.7. Business performance
9.2.8. Key strategic moves and developments
9.3. AROMATAGROUP SRL
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Key strategic moves and developments
9.4. BASF SE
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. DIVIS LABORATORIES LTD.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. DOEHLER GROUP SE
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. EXCELVITE
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Givaudan International SA (NATUREX S. A.)
9.8.1. Company overview
9.8.2. Key executive
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. R&D expenditure
9.8.7. Business performance
9.8.8. Key strategic moves and developments
9.9. KALSEC INC.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. KONINKLIJKE DSM N. V.
9.10.1. Company overview
9.10.2. Key executive
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. R&D expenditure (Continued and discontinued operations)
9.10.7. Business performance (Continued and discontinued operations)
List of Tables
TABLE 01. GLOBAL LYCOPENE MARKET, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 02. GLOBAL POWDER LYCOPENE MARKET, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 03. GLOBAL OTHERS LYCOPENE MARKET, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 04. GLOBAL LYCOPENE MARKET, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 05. GLOBAL NATURAL LYCOPENE MARKET, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 06. GLOBAL SYNTHETIC LYCOPENE MARKET, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 07. GLOBAL LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 08. GLOBAL LYCOPENE MARKET FOR FOOD AND BEVERAGE INDUSTRY, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 09. GLOBAL LYCOPENE MARKET FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 10. GLOBAL LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 11. GLOBAL LYCOPENE MARKET, BY REGION, 2020-2030 ($ THOUSAND)
TABLE 12. NORTH AMERICA LYCOPENE MARKET VALUE, BY FORM 2020-2030 ($ THOUSAND)
TABLE 13. NORTH AMERICA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 14. NORTH AMERICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 15. NORTH AMERICA LYCOPENE MARKET VALUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 16. U.S. LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 17. U.S. LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 18. U.S. LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 19. CANADA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 20. CANADA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 21. CANADA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 22. MEXICO LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 23. MEXICO LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 24. MEXICO LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 25. EUROPE LYCOPENE MARKET VALUE, BY FORM 2020-2030 ($ THOUSAND)
TABLE 26. EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 27. EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 28. EUROPE LYCOPENE MARKET VALUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 29. UK LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 30. UK LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 31. UK LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 32. GERMANY LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 33. GERMANY LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 34. GERMANY LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 35. FRANCE LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 36. FRANCE LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 37. FRANCE LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 38. ITALY LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 39. ITALY LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 40. ITALY LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 41. SPAIN LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 42. SPAIN LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 43. SPAIN LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 44. REST OF EUROPE LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 45. REST OF EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 46. REST OF EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 47. ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM 2020-2030 ($ THOUSAND)
TABLE 48. ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 49. ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 50. ASIA-PACIFIC LYCOPENE MARKET VALUE, BY COUNTRY, 2020-2030 ($ THOUSAND)
TABLE 51. CHINA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 52. CHINA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 53. CHINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 54. JAPAN LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 55. JAPAN LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 56. JAPAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 57. INDIA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 58. INDIA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 59. INDIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 60. ASEAN LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 61. ASEAN LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 62. ASEAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 63. AUSTRALIA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 64. AUSTRALIA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 65. AUSTRALIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 66. SOUTH KOREA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 67. SOUTH KOREA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 68. SOUTH KOREA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 69. REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 70. REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 71. REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 72. LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 73. LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 74. LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 75. LAMEA LYCOPENE MARKET VALUE, BY COUNTRY, 2020-2030 ($ MILLION)
TABLE 76. BRAZIL LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 77. BRAZIL LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 78. BRAZIL LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 79. ARGENTINA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 80. ARGENTINA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 81. ARGENTINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 82. SAUDI ARABIA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 83. SAUDI ARABIA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 84. SAUDI ARABIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 85. SOUTH AFRICA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 86. SOUTH AFRICA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 87. SOUTH AFRICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 88. REST OF LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020-2030 ($ THOUSAND)
TABLE 89. REST OF LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020-2030 ($ THOUSAND)
TABLE 90. REST OF LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020-2030 ($ THOUSAND)
TABLE 91. ALLIED BIOTECH CORPORATION: COMPANY SNAPSHOT
TABLE 92. ALLIED BIOTECH CORPORATION: OPERATING SEGMENTS
TABLE 93. ALLIED BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 94. ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 95. ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 96. ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 97. ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 98. ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 99. ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 100. AROMATAGROUP SRL: KEY EXECUTIVES
TABLE 101. AROMATAGROUP SRL: COMPANY SNAPSHOT
TABLE 102. AROMATAGROUP SRL: OPERATING SEGMENTS
TABLE 103. AROMATAGROUP SRL: PRODUCT PORTFOLIO
TABLE 104. BASF SE: KEY EXECUTIVES
TABLE 105. BASF SE: COMPANY SNAPSHOT
TABLE 106. BASF SE: OPERATING SEGMENTS
TABLE 107. BASF SE: PRODUCT PORTFOLIO
TABLE 108. BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 109. DIVIS LABORATORIES LTD.: KEY EXECUTIVES
TABLE 110. DIVIS LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 111. DIVIS LABORATORIES LTD.: OPERATING SEGMENTS
TABLE 112. DIVIS LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 113. DIVIS LABORATORIES LTD.: NET SALES, 2017-2019 ($MILLION)
TABLE 114. DOEHLER GROUP SE: KEY EXECUTIVES
TABLE 115. DOEHLER GROUP SE: COMPANY SNAPSHOT
TABLE 116. DOEHLER GROUP SE: OPERATING SEGMENTS
TABLE 117. DOEHLER GROUP SE: PRODUCT PORTFOLIO
TABLE 118. EXCELVITE: KEY EXECUTIVES
TABLE 119. EXCELVITE: COMPANY SNAPSHOT
TABLE 120. EXCELVITE: OPERATING SEGMENTS
TABLE 121. EXCELVITE: PRODUCT PORTFOLIO
TABLE 122. GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 123. GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 124. GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 125. GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 126. GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 127. GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 128. KALSEC INC: KEY EXECUTIVES
TABLE 129. KALSEC INC: COMPANY SNAPSHOT
TABLE 130. KALSEC INC: OPERATING SEGMENTS
TABLE 131. KALSEC INC: PRODUCT PORTFOLIO
TABLE 132. KONINKLIJKE DSM N. V.: KEY EXECUTIVE
TABLE 133. KONINKLIJKE DSM N. V.: COMPANY SNAPSHOT
TABLE 134. KONINKLIJKE DSM N. V.: OPERATING SEGMENTS
TABLE 135. KONINKLIJKE DSM N. V.: PRODUCT PORTFOLIO
TABLE 136. KONINKLIJKE DSM N. V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 137. KONINKLIJKE DSM N. V.: NET SALES, 2018-2020 ($MILLION)
List of Figures
FIGURE 01. LYCOPENE MARKET OVERVIEW
FIGURE 02. KEY MARKET SEGMENTS
FIGURE 03. EXECUTIVE SUMMARY
FIGURE 04. TOP IMPACTING FACTORS
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTION
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 11. GLOBAL LYCOPENE MARKET, BY FORM, 2020 (%)
FIGURE 12. COMPARATIVE VALUE SHARE ANALYSIS OF POWDER LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 13. COMPARATIVE VALUE SHARE ANALYSIS OF OTHERS LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. GLOBAL LYCOPENE MARKET, BY NATURE, 2020 (%)
FIGURE 15. COMPARATIVE VALUE SHARE ANALYSIS OF GLOBAL NATURAL LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE VALUE SHARE ANALYSIS OFSYNTHETIC LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. GLOBAL LYCOPENE MARKET, BY APPLICATION, 2020 (%)
FIGURE 18. COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE FOR FOOD AND BEVERAGEINDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE SALES FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20. COMPARATIVE VALUE SHARE ANALYSIS OF SALES OF LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. GLOBAL LYCOPENE MARKET, BY REGION 2020 (%)
FIGURE 22. U.S. LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 23. CANADA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 24. MEXICO LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 25. UK LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 26. GERMANY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 27. FRANCE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 28. ITALY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 29. SPAIN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 30. REST OF EUROPE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 31. CHINA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 32. JAPAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 33. INDIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 34. ASEAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 35. AUSTRALIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 36. SOUTH KOREA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 37. REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 38. BRAZIL LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 39. ARGENTINA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 40. SAUDI ARABIA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 41. SOUTH AFRICA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 42. REST OF LAMEA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 43. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 44. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR, 2018-2021*
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021* (%)
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021*
FIGURE 49. PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 50. ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 51. ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 52. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53. ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54. BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 55. BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56. BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57. DIVIS LABORATORIES LTD.: NET SALES, 2017-2019 ($MILLION)
FIGURE 58. DIVIS LABORATORIES LTD.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59. GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 60. GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 61. GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62. GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63. KONINKLIJKE DSM N. V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 64. KONINKLIJKE DSM N. V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 65. KONINKLIJKE DSM N. V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66. KONINKLIJKE DSM N. V.: REVENUE SHARE BY REGION, 2020 (%)
Note: Product cover images may vary from those shown
  • Allied Biotech Corporation
  • Archer-Daniels-Midland Company
  • AromataGroup SRL
  • BASF SE
  • Divis Laboratories Ltd.
  • Doehler Group SE
  • ExcelVite
  • Givaudan International SA
  • Kalsec Inc.
  • Koninklijke DSM N.V.
  • Chr Hasen A/S
  • DDW The Color
  • International Flavors & Fragrances Inc.
  • Sensient Technologies Corporation
  • Cyanotech Corporation
  • Kemin Industries, Inc.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...